AffRegInc.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « AffRegInc.i » - entrée « Nagoya »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nagasaki University Graduate School of Biomedical Sciences < Nagoya < Nagoya  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000163 (2020) Kyosuke Hattori [Japon] ; Yuji Hirano [Japon] ; Yasuhide Kanayama [Japon] ; Yosuke Hattori [Japon] ; Takefumi Kato [Japon] ; Nobunori Takahashi [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.
000437 (2019) Yuri Mizuno [Japon] ; Koji Shinoda [Japon] ; Mitsuru Watanabe [Japon] ; Hidenori Ogata [Japon] ; Noriko Isobe [Japon] ; Takuya Matsushita [Japon] ; Ryo Yamasaki [Japon] ; Kimihiro Tanaka [Japon] ; Haruki Koike [Japon] ; Masahisa Katsuno [Japon] ; Jun-Ichi Kira [Japon]Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: A case report.
000509 (2019) Shuji Asai [Japon] ; Masatoshi Hayashi [Japon] ; Masahiro Hanabayashi [Japon] ; Yasuhide Kanayama [Japon] ; Toki Takemoto [Japon] ; Yuichiro Yabe [Japon] ; Tomone Shioura [Japon] ; Hisato Ishikawa [Japon] ; Yutaka Yoshioka [Japon] ; Takefumi Kato [Japon] ; Yuji Hirano [Japon] ; Takayoshi Fujibayashi [Japon] ; Yosuke Hattori [Japon] ; Tomonori Kobayakawa [Japon] ; Masahiko Ando [Japon] ; Yachiyo Kuwatsuka [Japon] ; Nobunori Takahashi [Japon] ; Takuya Matsumoto [Japon] ; Nobuyuki Asai [Japon] ; Yasumori Sobue [Japon] ; Tsuyoshi Nishiume [Japon] ; Mochihito Suzuki [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
000B35 (2017) Shiho Iwagaitsu [Japon] ; Taio Naniwa [Japon]Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab.
000E28 (2016) Toshihisa Kojima [Japon] ; Nobunori Takahashi ; Koji Funahashi ; Shuji Asai ; Kenya Terabe ; Atsushi Kaneko [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Takeshi Oguchi [Japon] ; Hideki Takagi [Japon] ; Yasuhide Kanayama [Japon] ; Yuichiro Yabe [Japon] ; Tsuyoshi Watanabe [Japon] ; Takayoshi Fujibayashi [Japon] ; Tomone Shioura [Japon] ; Takayasu Ito [Japon] ; Yutaka Yoshioka [Japon] ; Hisato Ishikawa [Japon] ; Nobuyuki Asai ; Toki Takemoto ; Masayo Kojima [Japon] ; Naoki IshiguroImproved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
000F30 (2016) Toshikazu Ozeki [Japon] ; Yoshiro Fujita [Japon]Asymptomatic colitis induced by low-dose methotrexate.
001013 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
001101 (2015) Toshihisa Kojima [Japon] ; Yuichiro Yabe [Japon] ; Atsushi Kaneko [Japon] ; Nobunori Takahashi [Japon] ; Koji Funahashi [Japon] ; Daizo Kato [Japon] ; Masahiro Hanabayashi [Japon] ; Shuji Asai [Japon] ; Shinya Hirabara [Japon] ; Nobuyuki Asai [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Masayo Kojima [Japon] ; Naoki Ishiguro [Japon]Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
001354 (2014) Nobuyuki Watanabe [Japon] ; Hirotaka Iguchi [Japon] ; Hiroto Mitsui [Japon] ; Kaneaki Tawada [Japon] ; Satona Murakami [Japon] ; Takanobu Otsuka [Japon]Hip Arthroscopic Synovectomy and Labral Repair in a Patient With Rheumatoid Arthritis With a 2-Year Follow-up.
001708 (2012) Toshihisa Kojima [Japon] ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Hiroyuki Miyake ; Takeshi Oguchi ; Hideki Takagi ; Yuichiro Yabe ; Takefumi Kato ; Takayasu Ito ; Kenya Terabe ; Naoki Fukaya ; Yasuhide Kanayama ; Tomone Shioura ; Koji Funahashi ; Masatoshi Hayashi ; Daizo Kato ; Hiroyuki Matsubara ; Takayoshi Fujibayashi ; Masayo Kojima ; Naoki IshiguroStudy protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study.
001780 (2012) Toshihisa Kojima [Japon] ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Hiroyuki Miyake ; Hideki Takagi ; Yuichiro Yabe ; Takefumi Kato ; Kenya Terabe ; Naoki Fukaya ; Hiroki Tsuchiya ; Tomone Shioura ; Koji Funahashi ; Masatoshi Hayashi ; Daizo Kato ; Hiroyuki Matsubara ; Naoki IshiguroEarly aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice.
001A70 (2009) Yukio Mano [Japon] ; Kiyosumi Shibata ; Seiji Sumigama ; Hiromi Hayakawa ; Kazuhiko Ino ; Eiko Yamamoto ; Hiroaki Kajiyama ; Akihiro Nawa ; Fumitaka KikkawaTocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes.
001D16 (????) Sasha Bogdanovich [États-Unis] ; Younghee Kim [États-Unis] ; Takeshi Mizutani [Japon] ; Reo Yasuma [Japon] ; Laura Tudisco [Italie] ; Valeria Cicatiello [Italie] ; Ana Bastos-Carvalho [États-Unis] ; Nagaraj Kerur [États-Unis] ; Yoshio Hirano [États-Unis] ; Judit Z. Baffi [États-Unis] ; Valeria Tarallo [Italie] ; Shengjian Li [États-Unis] ; Tetsuhiro Yasuma [États-Unis] ; Parthasarathy Arpitha [États-Unis] ; Benjamin J. Fowler [États-Unis] ; Charles B. Wright [États-Unis] ; Ivana Apicella [Italie] ; Adelaide Greco [Italie] ; Arturo Brunetti [Italie] ; Menotti Ruvo [Italie] ; Annamaria Sandomenico [Italie] ; Miho Nozaki [Japon] ; Ryo Ijima [Japon] ; Hiroki Kaneko [Japon] ; Yuichiro Ogura [Japon] ; Hiroko Terasaki [Japon] ; Balamurali K. Ambati [États-Unis] ; Jeanette Hw Leusen [Pays-Bas] ; Wallace Y. Langdon [Australie] ; Michael R. Clark [Royaume-Uni] ; Kathryn L. Armour [Royaume-Uni] ; Pierre Bruhns [France] ; J Sjef Verbeek [Pays-Bas] ; Bradley D. Gelfand [États-Unis] ; Sandro De Falco [Italie] ; Jayakrishna Ambati [États-Unis]Human IgG1 antibodies suppress angiogenesis in a target-independent manner.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i -k "Nagoya" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i  \
                -Sk "Nagoya" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Nagoya
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021